Farmax India - News

NSE: FARMAXIND | BSE: 590094

₹0.05

₹0.00 (0.00%)

As on 02-Jul-2018IST

Market cap

₹5 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

--

P/B Ratio

-0.3

Div. Yield

0 %

Annual Reports

Annual Reports

2016

Annual Reports

2015

Annual Reports

2014

Annual Reports

2013

Annual Reports

2012

Annual Reports

2011

Annual Reports

2010

Announcements

View Announcements

Recent

Important

Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016

13-Feb-2017

Board Meeting Intimation for Results & Closure of Trading Window

31-Jan-2017

Shareholding for the Period Ended December 31, 2016

21-Jan-2017

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

11-Jan-2017

Revised Financial Results for September 30, 2016

16-Nov-2016

Standalone Financial Results, Limited Review Report for September 30, 2016

11-Nov-2016

Board Meeting Intimation for Results & Closure of Trading Window

25-Oct-2016

Shareholding for the Period Ended September 30, 2016

14-Oct-2016

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016

14-Oct-2016

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

01-Oct-2016